Trial Search Results

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Center for International Blood and Marrow Transplant Research

Collaborator: National Marrow Donor Program

Stanford Investigator(s):

Intervention(s):

  • Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)

Eligibility


Inclusion Criteria:

   - Disorders affecting the hematopoietic system that are inherited, acquired, or result
   from myeloablative treatment

   - Signed informed consent (and signed assent, if applicable) obtained prior to study
   enrollment

   - Pediatric and adult patients of any age

Exclusion Criteria:

   - Patients who are receiving only licensed CBUs

   - Cord blood transplant recipients at international transplant centers

   - Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)

   - Patients whose selected unlicensed CBU(s) will be more than minimally manipulated

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sandhya Kharbanda, MD
Not Recruiting